satsumarx.com
  • About Us
    • Overview
    • Leadership
    • Board of Directors
    • Join Our Team
  • Our Focus
    • Migraine
    • SMART Platform
  • Our Product
    • Atzumi™
  • News
    • Publications
    • Press Releases
  • Contact

Long-term safety and tolerability of STS101, a novel investigational dihydroergotamine nasal powder: initial data from the ASCEND study 

satsumarx.com
  • About Us
    • Overview
    • Leadership
    • Board of Directors
    • Join Our Team
  • Our Focus
    • Migraine
    • SMART Platform
  • Our Product
    • Atzumi™
  • News
    • Publications
    • Press Releases
  • Contact

 ©2026 Satsuma Pharmaceuticals, Inc. All Rights Reserved. | Terms of Use | Privacy Policy

  • About Us
    • Overview
    • Leadership
    • Board of Directors
    • Join Our Team
  • Our Focus
    • Migraine
    • SMART Platform
  • Our Product
    • Atzumi™
  • News
    • Publications
    • Press Releases
  • Contact